Videos

calanderBy Prof. Sven Francquecalander27 July 2022
GETTING TO THE HEART OF NAFLD/NASH – THE CVD PERSPECTIVE (PART 3)

In this video, Prof. Sven Francque (Belgium) discusses how vascular mechanisms contribute to non-alcoholic fatty liver disease (NAFLD) and how non-alcoholic steatohepatitis (NASH) contributes to cardiovascular disease (CVD). He also mentions that drugs used to prevent/treat CVD and NAFLD/NASH are safe and those that are used to prevent/treat CVD can have some benefits for NAFLD.